JESSE TREVINO: Open Payments
NPI 1639340144 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 69 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $38 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $211 |
| Corcept Therapeutics | 9 | $190 |
| ABBVIE INC. | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| PFIZER INC. | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
Products named: Korlym, VRAYLAR, DEXCOM G7 GSS (161), Dexcom G6 Transmitter, Kerendia, REXULTI, Symbravo, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
